Krajina: Austrália
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
hydrochlorothiazide, Quantity: 25 mg; telmisartan, Quantity: 80 mg
Alembic Pharmaceuticals Australia Pty Ltd
Hydrochlorothiazide,Telmisartan
Tablet, multilayer
Excipient Ingredients: meglumine; sodium hydroxide; mannitol; povidone; magnesium stearate; lactose monohydrate; purified water; sodium stearylfumarate; Colour
Oral
28
(S4) Prescription Only Medicine
TELMISARTAN HCT APA is indicated for the treatment of hypertension. Treatment should not be initiated with these combinations.
Visual Identification: Oblong shaped, biconvex, bilayered, uncoated tablets with one white/off white color layer and one yellow colour mottled layer debossed with L201; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2016-08-19